Athenex, Inc. (ATNX) financial statements (2022 and earlier)

Company profile

Business Address 1001 MAIN STREET
BUFFALO, NY 14203
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,409208,223160,813107,42351,037
Cash and cash equivalents35,20269,587127,67449,79439,284
Short-term investments10,207138,63633,13957,62911,753
Restricted cash and investments16,50016,500   
Receivables26,63723,60316,68912,9518,468
Inventory, net of allowances, customer advances and progress billings34,68528,84632,63028,78716,561
Inventory34,68528,84632,63028,78716,561
Deferred costs    200
Disposal group, including discontinued operation1,280    
Other undisclosed current assets8,88514,78920,79421,6587,492
Total current assets:133,396291,961230,926170,81983,758
Noncurrent Assets
Operating lease, right-of-use asset6,2437,9218,818
Property, plant and equipment27,97834,38823,15311,4479,651
Long-term investments and receivables    328
Long-term investments    328
Intangible assets, net (including goodwill)71,89649,10947,03548,34346,367
Goodwill 38,89138,51337,49537,795
Intangible assets, net (excluding goodwill)71,89610,2188,52210,8488,572
Disposal group, including discontinued operation, noncurrent assets26,848    
Other noncurrent assets1,087950  188
Deferred tax assets, net486121
Total noncurrent assets:134,05292,36879,00660,27656,655
TOTAL ASSETS:267,448384,329309,932231,095140,413
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41,19556,94667,63850,71543,637
Accounts payable16,74218,67323,33112,99716,659
Accrued liabilities24,45338,27344,30737,71826,978
Debt46,8812,0108809611,015
Due to related parties    491
Disposal group, including discontinued operation5,062    
Other undisclosed current liabilities2,9093,1853,010  
Total current liabilities:96,04762,14171,52851,67645,143
Noncurrent Liabilities
Long-term debt and lease obligation4,7016,8927,84745,803475
Long-term debt, excluding current maturities   45,381 
Finance lease, liability207537227
Capital lease obligations422475
Operating lease, liability4,4946,3557,620
Liabilities, other than long-term debt28,9993,9082,5634,8474,073
Deferred revenue and credits1,760
Deferred compensation liability, classified   2,8252,313
Deferred rent credit   2,022
Deferred income tax liabilities1,75156 
Disposal group, including discontinued operation, liabilities126    
Other liabilities3,0463,8522,563  
Business combination, contingent consideration, liability24,076    
Other undisclosed noncurrent liabilities103,249146,04052,139  
Total noncurrent liabilities:136,949156,84062,54950,6504,548
Total liabilities:232,996218,981134,077102,32649,691
Stockholders' equity
Stockholders' equity attributable to parent51,131179,775188,225139,35590,037
Common stock11195836960
Treasury stock, value(7,485)(7,406)(7,406)(7,406)(7,406)
Additional paid in capital972,404901,864763,648591,064423,805
Accumulated other comprehensive loss(487)(1,134)(635)(656)(146)
Accumulated deficit(913,412)(713,644)(567,465)(443,716)(326,276)
Stockholders' equity attributable to noncontrolling interest(16,679)(14,427)(12,370)(10,586)685
Total stockholders' equity:34,452165,348175,855128,76990,722
TOTAL LIABILITIES AND EQUITY:267,448384,329309,932231,095140,413

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues120,181144,391101,22989,10038,043
Revenue, net38,043
Cost of revenue
(Cost of Goods and Services Sold)
(82,406)(95,355)(69,619)(47,005)(25,122)
Gross profit:37,77549,03631,61042,09512,921
Operating expenses(222,169)(172,759)(151,142)(168,913)(122,909)
Operating loss:(184,394)(123,723)(119,532)(126,818)(109,988)
Nonoperating income
(Investment Income, Nonoperating)
2278741,881  
Interest and debt expense(20,742)(21,497)(6,954) (5,912)
Loss from continuing operations before equity method investments, income taxes:(204,909)(144,346)(124,605)(126,818)(115,900)
Other undisclosed loss from continuing operations before income taxes   (1,793)(15,411)
Loss from continuing operations before income taxes:(204,909)(144,346)(124,605)(128,611)(131,311)
Income tax expense (benefit)10,604(4,088)(928)(100)(85)
Loss from continuing operations:(194,305)(148,434)(125,533)(128,711)(131,396)
Loss from discontinued operations(7,731)    
Net loss:(202,036)(148,434)(125,533)(128,711)(131,396)
Net income attributable to noncontrolling interest2,2682,2551,78411,271226
Net loss available to common stockholders, diluted:(199,768)(146,179)(123,749)(117,440)(131,170)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(202,036)(148,434)(125,533)(128,711)(131,396)
Other comprehensive income (loss)647(499)21(510)1,158
Comprehensive loss:(201,389)(148,933)(125,512)(129,221)(130,238)
Comprehensive income, net of tax, attributable to noncontrolling interest2,2682,2551,78411,271226
Comprehensive loss, net of tax, attributable to parent:(199,121)(146,678)(123,728)(117,950)(130,012)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: